[EN] COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS<br/>[FR] COMPOSÉS UTILES POUR LE TRAITEMENT DE TROUBLES DU TRACTUS DIGESTIF
申请人:ARDELYX INC
公开号:WO2018129552A1
公开(公告)日:2018-07-12
The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist- induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.
本公开涉及化合物和治疗与液体潴留或盐过多有关的疾病的方法,例如心力衰竭(特别是充血性心力衰竭)、慢性肾病、晚期肾病、肝病和过氧化物酶体增殖物激活受体(PPAR)γ激动剂诱导的液体潴留。本公开还涉及化合物和治疗高血压的方法。本公开还涉及化合物和治疗胃肠道疾病的方法,包括治疗或减轻与胃肠道疾病相关的疼痛。